The EPA has proposed to rescind the 2009 decision that allowed it to regulate greenhouse gases as pollutants under the Clean Air Act.

After adjusting for confounding factors, patients with CSU experience worse health outcomes and quality of life than patients with AD or PsO.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.